CD44 and neoplasm: Furthermore, in a post-radiation tumor recurrence model, only 25% of mice exhibited recurrent tumor growth when treated with H4C4, compared to 90% of mice treated with radiation alone, indicating that the CD44+ tumor initiating population had been eradicated by H4C4 treatment [134].